Laurenzi L, Natoli S, Di Filippo F, Calamaro A, Centulio F, Anzà M, Cavaliere F, Marcelli M E, Garinei R, Arcuri E
Intensive Care Unit, Regina Elena National Cancer Institute, Rome, Italy.
J Exp Clin Cancer Res. 2004 Jun;23(2):225-31.
The aim of this study was to evaluate the systemic and haemodynamic postoperative effects of ILP with medium-low dose of TNF alpha in patients diagnosed with primary or recurrent limb melanoma or sarcoma, and to compare the resulting toxicity with Systemic Inflammatory Response Syndrome (SIRS). A prospective study on 17 consecutive patients with primary or recurrent limb tumor (melanoma or sarcoma) subjected to ILP with escalating doses of TNF alpha (0.5-2.0mg) was carried out. Seventeen patients with primary or recurrent limb melanoma or sarcoma were subjected to ILP with escalating doses of TNF alpha. ILP was carried out with the standard techniques, blood being warmed at 42 degrees C for an hour. Serial serum TNF alpha determinations were performed before, during and after limb perfusion in nine patients. Systemic and pulmonary haemodynamics, by a radial and pulmonary artery catheter inserted before the induction of anesthesia, were monitored at 5 different times: before the induction of anesthesia (T0), and 6, 12, 24 and 48 hours after treatment (T1-4). Complete isolation of the limb was not always achieved, therefore leakage of TNF alpha occurred frequently during the perfusion in all patients with maximum systemic TNF alpha concentrations ranging from 431 to 111000 pg/ml. After perfusion only two patients showed detectable TNF alpha levels in peripheral blood which returned to baseline values within nine hours. These two patients had serious systemic toxicity: shock and respiratory failure secondary to pulmonary edema. Acute pulmonary edema was also observed in another patient. All three cases required supportive therapy provided by means of mechanical ventilation. In the remaining 14 patients a sepsis-like syndrome was observed. The most significant haemodynamic changes were due to the CO, which rose by 35%, and the SVR, which remained consistently low throughout. A reduction in Hb was observed in all patients (with an average decrease of 4 g/dl), while DO2 and VO2 levels rose, though not to statistically significant levels. Hypoxia occurred in all 14 patients. In three of the remaining 14 cases bilateral pulmonary leaks were noted, however the use of mechanical ventilation was not required. No perioperative death occurred and the aforementioned side effects were all reversible resulting in a patient's mean postoperative ICU permanence of 4 days (range 3 to 7 days). In conclusion, ILP with TNF alpha induces cardiovascular, respiratory and hematological toxicity with haemodynamic parameters being similar to those noted in SIRS probably due to leakage of TNF alpha in the systemic circulation during the perfusion. Nevertheless, this systemic toxicity was short-lived resulting in an acute reaction following a single application.
本研究的目的是评估中低剂量肿瘤坏死因子α(TNFα)隔离肢体灌注(ILP)对诊断为原发性或复发性肢体黑色素瘤或肉瘤患者的全身及血流动力学术后影响,并将由此产生的毒性与全身炎症反应综合征(SIRS)进行比较。对17例连续的原发性或复发性肢体肿瘤(黑色素瘤或肉瘤)患者进行了递增剂量TNFα(0.5 - 2.0mg)的ILP前瞻性研究。17例原发性或复发性肢体黑色素瘤或肉瘤患者接受了递增剂量TNFα的ILP。ILP采用标准技术进行,血液在42℃加热1小时。对9例患者在肢体灌注前、灌注期间和灌注后进行了血清TNFα的系列测定。通过在麻醉诱导前插入的桡动脉和肺动脉导管监测全身和肺血流动力学,在5个不同时间点进行:麻醉诱导前(T0),以及治疗后6、12、24和48小时(T1 - 4)。并非总能完全隔离肢体,因此在所有患者的灌注过程中TNFα经常发生渗漏,全身最大TNFα浓度范围为431至111000 pg/ml。灌注后仅2例患者外周血中检测到TNFα水平,且在9小时内恢复至基线值。这2例患者出现严重的全身毒性:继发于肺水肿的休克和呼吸衰竭。在另一例患者中也观察到急性肺水肿。所有3例病例均需要机械通气提供支持治疗。在其余14例患者中观察到类似脓毒症的综合征。最显著的血流动力学变化归因于心输出量(CO)升高35%,而全身血管阻力(SVR)始终保持在较低水平。所有患者均观察到血红蛋白(Hb)降低(平均下降4 g/dl),而氧输送(DO2)和氧消耗(VO2)水平升高,但未达到统计学显著水平。其余14例患者均出现低氧血症。在其余14例中的3例中发现双侧肺渗漏,但无需使用机械通气。围手术期无死亡发生,上述副作用均为可逆性,患者术后在重症监护病房(ICU)的平均停留时间为4天(范围3至7天)。总之,TNFα的ILP诱导心血管、呼吸和血液学毒性,其血流动力学参数与SIRS中观察到的参数相似,这可能是由于灌注期间TNFα在体循环中渗漏所致。然而,这种全身毒性是短暂的,单次应用后会导致急性反应。